[Incidence of benign and malignant lesions of eyelid and conjunctival tumors]
- PMID: 16218435
[Incidence of benign and malignant lesions of eyelid and conjunctival tumors]
Abstract
Purpose: To examine the incidence of benign and malignant eyelid lesions and conjunctival tumors.
Subjects and methods: One-hundred-and twenty-eight cases (131 eyes) which were treated during the period from January 1990 to February 2004 were histopathologically diagnosed for eyelid or conjunctival tumors (87 cases of eyelid tumors and 41 cases of conjunctival tumors) in retrospective evaluations. The incidence of benign or malignant lesions, the pathological classification, age, sex, and clinical diagnostic accuracy were all investigated.
Results: Sixty-four (73%) of the tumors were found to be benign eyelid tumors. The common benign eyelid tumors were 14 nevocellular nevi, 9 seborrheic keratosis, 7 epidermoid cysts, and 6 papillomas. Twenty-four (27%) eyelid tumors were malignant. These included 9 basal cell carcinomas, 9 sebaceous gland carcinomas, 4 malignant lymphomas, and 2 metastatic tumors. Thirty-four (79%) conjunctival tumors were benign, and the common benign conjunctival tumors were 9 nevocellular nevi and 7 papillomas. Nine (21%) conjunctival tumors were malignant, comprising 7 malignant lymphomas and 2 squamous cell carcinomas. The mean ages of malignant eyelid and conjunctival tumor patients were significantly older than those of benign tumor patients. Clinical accuracy in predicting basal cell carcinoma and sebaceous gland carcinoma was 11.1% and 44.4%, respectively.
Conclusions: Approximately 70 approximately 80% of all eyelid and conjunctival tumors are benign. Clinicians should suspect that the lesions are malignant when seeing elderly patients with eyelid or conjunctival tumors. Excised eyelid lesions should be submitted for histopathologic confirmation because there are some cases where clinical diagnosis does not match pathological diagnosis.
Similar articles
-
Clinical analysis of benign eyelid and conjunctival tumors.Ophthalmologica. 2006;220(1):43-51. doi: 10.1159/000089274. Ophthalmologica. 2006. PMID: 16374048
-
Eyelid tumours and pseudotumours in Hong Kong: a ten-year experience.Hong Kong Med J. 2013 Apr;19(2):150-5. Hong Kong Med J. 2013. PMID: 23535675
-
Eyelid tumors in Siriraj Hospital from 2000-2004.J Med Assoc Thai. 2005 Nov;88 Suppl 9:S11-4. J Med Assoc Thai. 2005. PMID: 16681045
-
Eyelid and ocular surface carcinoma: diagnosis and management.Clin Dermatol. 2015 Mar-Apr;33(2):159-69. doi: 10.1016/j.clindermatol.2014.10.008. Clin Dermatol. 2015. PMID: 25704936 Review.
-
Clinicopathological features of eyelid skin tumors. A retrospective study of 5504 cases and review of literature.Am J Dermatopathol. 2009 May;31(3):256-62. doi: 10.1097/DAD.0b013e3181961861. Am J Dermatopathol. 2009. PMID: 19384066 Review.
Cited by
-
MicroRNA and transcriptome analysis in periocular Sebaceous Gland Carcinoma.Sci Rep. 2018 May 14;8(1):7531. doi: 10.1038/s41598-018-25900-z. Sci Rep. 2018. PMID: 29760516 Free PMC article.
-
Analysis of hedgehog signaling in periocular sebaceous carcinoma.Graefes Arch Clin Exp Ophthalmol. 2018 Apr;256(4):853-860. doi: 10.1007/s00417-018-3900-5. Epub 2018 Feb 8. Graefes Arch Clin Exp Ophthalmol. 2018. PMID: 29423837 Free PMC article.
-
Epidemiological characteristics of malignant eyelid tumors at a referral hospital in Japan.Jpn J Ophthalmol. 2022 Jul;66(4):343-349. doi: 10.1007/s10384-022-00926-z. Epub 2022 Jun 7. Jpn J Ophthalmol. 2022. PMID: 35670924
-
Periocular basal cell carcinoma results and surgical outcome during a 5-year period in a larger Danish population.BMC Ophthalmol. 2022 Jun 28;22(1):282. doi: 10.1186/s12886-022-02494-9. BMC Ophthalmol. 2022. PMID: 35761210 Free PMC article.
-
Eyelid sebaceous gland carcinoma: Varied presentations and reconstruction outcome.Oman J Ophthalmol. 2018 Jan-Apr;11(1):21-27. doi: 10.4103/ojo.OJO_139_2017. Oman J Ophthalmol. 2018. PMID: 29563690 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources